Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Assess the Efficacy, Safety, and Tolerability of Multiple Subcutaneous Injections of Depot Buprenorphine (RBP-6000 [100 mg and 300 mg]) Over 24 Weeks in Treatment-Seeking Subjects With Opioid Use Disorder
Conditions
Interventions
SUBOXONE
RBP-6000
+1 more
Locations
38
United States
Haleyville Clinical Research
Haleyville, Alabama, United States
Boyett Health Services
Hamilton, Alabama, United States
Woodland International Research Group
Little Rock, Arkansas, United States
Collaborative Neuroscience Network
Garden Grove, California, United States
Behavioral Research Specialists
Glendale, California, United States
Synergy Clinical Research Center
National City, California, United States
Start Date
January 28, 2015
Primary Completion Date
April 29, 2016
Completion Date
April 29, 2016
Last Updated
February 20, 2018
NCT05463367
NCT03345173
NCT04454411
NCT03842137
NCT06442306
NCT05995873
Lead Sponsor
Indivior Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions